These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 17914972

  • 21. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
    Fung J, Cheung C, Chan SC, Yuen MF, Chok KS, Sharr W, Dai WC, Chan AC, Cheung TT, Tsang S, Lam B, Lai CL, Lo CM.
    Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
    [Abstract] [Full Text] [Related]

  • 22. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
    Takahashi S, Kudo M, Chung H, Inoue T, Nagashima M, Kitai S, Tatsumi C, Minami Y, Ueshima K, Fukunaga T, Haji S.
    Dig Dis; 2007 Oct; 25(4):303-9. PubMed ID: 17960064
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study.
    Kudo M, Sakaguchi Y, Chung H, Hatanaka K, Hagiwara S, Ishikawa E, Takahashi S, Kitai S, Inoue T, Minami Y, Ueshima K.
    Oncology; 2007 Oct; 72 Suppl 1():132-8. PubMed ID: 18087194
    [Abstract] [Full Text] [Related]

  • 25. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK, HEPNET. Greece Cohort Study Group.
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma.
    Kim JH, Park JW, Kim TH, Koh DW, Lee WJ, Kim CM.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):813-9. PubMed ID: 17524569
    [Abstract] [Full Text] [Related]

  • 27. Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma.
    An HJ, Jang JW, Bae SH, Choi JY, Cho SH, Yoon SK, Han JY, Lee KH, Kim DG, Jung ES.
    J Gastroenterol Hepatol; 2010 Dec 01; 25(12):1876-82. PubMed ID: 21092000
    [Abstract] [Full Text] [Related]

  • 28. Antiviral therapy and long-term outcome for hepatitis B virus-related hepatocellular carcinoma after curative liver resection in a Japanese cohort.
    Sakamoto K, Beppu T, Hayashi H, Nakagawa S, Okabe H, Nitta H, Imai K, Hashimoto D, Chikamoto A, Isiko T, Kikuchi K, Baba H.
    Anticancer Res; 2015 Mar 01; 35(3):1647-55. PubMed ID: 25750323
    [Abstract] [Full Text] [Related]

  • 29. Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma.
    Shin HS, Kim SU, Park JY, Kim DY, Han KH, Chon CY, Baatarkhuu O, Ahn SH.
    J Gastroenterol Hepatol; 2012 Sep 01; 27(9):1528-34. PubMed ID: 22497450
    [Abstract] [Full Text] [Related]

  • 30. Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy.
    Nagamatsu H, Itano S, Nagaoka S, Akiyoshi J, Matsugaki S, Kurogi J, Tajiri N, Yamasaki S, Koga H, Torimura T, Kumashiro R, Sata M.
    Am J Gastroenterol; 2004 Dec 01; 99(12):2369-75. PubMed ID: 15571585
    [Abstract] [Full Text] [Related]

  • 31. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.
    Sun LJ, Yu JW, Zhao YH, Kang P, Li SC.
    J Gastroenterol Hepatol; 2010 Mar 01; 25(3):583-90. PubMed ID: 19968744
    [Abstract] [Full Text] [Related]

  • 32. Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine.
    Di Marco V, Marzano A, Lampertico P, Andreone P, Santantonio T, Almasio PL, Rizzetto M, Craxì A, Italian Association for the Study of the Liver (AISF) Lamivudine Study Group, Italy.
    Hepatology; 2004 Oct 01; 40(4):883-91. PubMed ID: 15382125
    [Abstract] [Full Text] [Related]

  • 33. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
    Sun LY, Zhu ZJ, Qu W, Sun XY, Rao W, Liu Y.
    Hepatogastroenterology; 2014 Oct 01; 61(135):2047-51. PubMed ID: 25713909
    [Abstract] [Full Text] [Related]

  • 34. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Liu J, Wu GC, Zhang ZT, Wu P, Zhang D, Sun MC, Gao DC, Wang Y, Jia JD, Wang BE.
    Zhonghua Wai Ke Za Zhi; 2005 Aug 01; 43(15):976-9. PubMed ID: 16194352
    [Abstract] [Full Text] [Related]

  • 35. High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma.
    Xia F, Lai EC, Lau WY, Ma K, Li X, Bie P, Qian C.
    Ann Surg Oncol; 2012 Apr 01; 19(4):1284-91. PubMed ID: 21913016
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
    Huang G, Lai EC, Lau WY, Zhou WP, Shen F, Pan ZY, Fu SY, Wu MC.
    Ann Surg; 2013 Mar 01; 257(3):490-505. PubMed ID: 22868358
    [Abstract] [Full Text] [Related]

  • 39. A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization.
    Jang JW, Choi JY, Bae SH, Yoon SK, Chang UI, Kim CW, Cho SH, Han JY, Lee YS.
    Hepatology; 2006 Feb 01; 43(2):233-40. PubMed ID: 16440357
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.